Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001
Assessment of cytokine mRNA expression in patients with COPD exacerbations Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
Expression of mRNA encoding IL-8 and CXCR‘s in blood and lavage of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Correlation of the interleukin-5 level in sputum and serum in asthma patients with the different polymorphism by C703-T (IL-5 gene) Source: Eur Respir J 2001; 18: Suppl. 33, 371s Year: 2001
An improved assay for detection of sputum periostin in patients with asthma Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020
Reproducible measurements of Th2-cytokines and RNA gene expression obtained in sputum from patients with allergic asthma following allergen challenge Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
Induced sputum free interleukin-5 level and its mRNA expression in atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 548s Year: 2003
Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Modulation of sputum gene expression in COPD by fluticasone/salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006
Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009
Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Cytokine profile of blood and sputum in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 502s Year: 2002
Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Expression of selected surface markers on macrophages in induced sputum from patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Gene expression profiling of induced sputum from COPD patients and healthy smokers Source: Eur Respir J 2006; 28: Suppl. 50, 746s Year: 2006
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010